Source 1primary paper2025MED
Toolkit/biparametric prostate MRI
biparametric prostate MRI
Also known as: biparametric MRI, bpMRI
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Both multiparametric MRI and biparametric MRI (bpMRI) are currently in use. This study aims to evaluate the role and accuracy of bpMRI in patients with prostate cancer.
Usefulness & Problems
Why this is useful
Biparametric prostate MRI is used here to localize and characterize prostate cancer lesions using MRI sequences evaluated in the study. The paper frames it as useful for diagnosis, extent assessment, and post-treatment monitoring.; diagnosing prostate cancer lesions; assessing extent of prostate cancer; monitoring patients post-treatment for early recurrence; treatment planning; assessing patient prognosis
Source:
Biparametric prostate MRI is used here to localize and characterize prostate cancer lesions using MRI sequences evaluated in the study. The paper frames it as useful for diagnosis, extent assessment, and post-treatment monitoring.
Source:
diagnosing prostate cancer lesions
Source:
assessing extent of prostate cancer
Source:
monitoring patients post-treatment for early recurrence
Source:
treatment planning
Source:
assessing patient prognosis
Problem solved
It addresses the need for imaging-based detection and assessment of prostate cancer lesions to support management decisions. The abstract also links the MRI information to treatment planning and prognosis assessment.; provides MRI-based localization and characterization of prostate cancer lesions
Source:
It addresses the need for imaging-based detection and assessment of prostate cancer lesions to support management decisions. The abstract also links the MRI information to treatment planning and prognosis assessment.
Source:
provides MRI-based localization and characterization of prostate cancer lesions
Problem links
provides MRI-based localization and characterization of prostate cancer lesions
LiteratureIt addresses the need for imaging-based detection and assessment of prostate cancer lesions to support management decisions. The abstract also links the MRI information to treatment planning and prognosis assessment.
Source:
It addresses the need for imaging-based detection and assessment of prostate cancer lesions to support management decisions. The abstract also links the MRI information to treatment planning and prognosis assessment.
Published Workflows
Objective: Evaluate the role and accuracy of biparametric MRI in patients with prostate cancer for diagnosis, extent assessment, and post-treatment early recurrence monitoring.
Why it works: The study evaluates MRI sequence findings in lesions that were later pathologically confirmed as prostate cancer, using pathology as the reference to assess how often specific MRI features are present in malignant lesions.
T2-weighted lesion hypointensitydiffusion restriction on DWI and ADC mapsT1-weighted lesion signal characterizationbiparametric MRIretrospective cohort analysispathology confirmation by biopsy or surgical resection
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Techniques
Functional AssayTarget processes
No target processes tagged yet.
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
The approach requires prostate MRI acquisition and interpretation of sequences including T2-weighted and diffusion-related imaging. In this study, lesion truth was established by biopsy or surgical resection pathology.; requires MRI examination; requires pathological confirmation by biopsy or surgical resection for ground-truth evaluation
The abstract does not show that bpMRI alone replaces pathology or establishes performance against multiparametric MRI. It also does not define how well it detects clinically significant disease by standard grading thresholds.; abstract does not report formal sensitivity, specificity, or comparison against multiparametric MRI; study is retrospective and limited to 50 pathologically confirmed cases
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
The study concludes that T2-weighted imaging has high accuracy in diagnosing malignant prostate lesions.
The findings of this study confirm the high accuracy of T2WI in diagnosing malignant prostate lesions.
Diffusion restriction was observed on diffusion-weighted imaging and ADC map sequences in 43 of 50 pathology-confirmed prostate cancer cases.
Diffusion restriction was observed on DWI and ADC map sequences in 43 (86%) of the cases.
cases with diffusion restriction on DWI and ADC maps 43 casescases with diffusion restriction on DWI and ADC maps 86 %total evaluated cases 50 cases
T2-weighted imaging showed hypointense lesions in 46 of 50 pathology-confirmed prostate cancer cases.
On T2WI, the lesions appeared hypointense in 46 (92%) of the 50 cases.
cases with hypointense lesions on T2WI 46 casescases with hypointense lesions on T2WI 92 %total evaluated cases 50 cases
On T1-weighted imaging, prostate cancer lesions were isointense in 47 of 50 cases and moderately hyperintense in 3 of 50 cases, particularly for lesions larger than 8 mm.
On T1WI, cancerous lesions were isointense in 47 (94%) cases and moderately hyperintense in three (6%) cases, particularly in lesions larger than 8 mm in diameter.
isointense lesions on T1WI 47 casesisointense lesions on T1WI 94 %lesion size association >8 mmmoderately hyperintense lesions on T1WI 3 casesmoderately hyperintense lesions on T1WI 6 %
This study evaluated the role and accuracy of biparametric MRI in prostate cancer for diagnosis, extent assessment, and post-treatment early recurrence monitoring.
This study aims to evaluate the role and accuracy of bpMRI in patients with prostate cancer, particularly for diagnosing clinically significant cancer, assessing its extent, and monitoring patients post-treatment for early recurrence.
Approval Evidence
1 source1 linked approval claimfirst-pass slug biparametric-prostate-mri
Both multiparametric MRI and biparametric MRI (bpMRI) are currently in use. This study aims to evaluate the role and accuracy of bpMRI in patients with prostate cancer.
Source:
study objectivesupports
This study evaluated the role and accuracy of biparametric MRI in prostate cancer for diagnosis, extent assessment, and post-treatment early recurrence monitoring.
This study aims to evaluate the role and accuracy of bpMRI in patients with prostate cancer, particularly for diagnosing clinically significant cancer, assessing its extent, and monitoring patients post-treatment for early recurrence.
Source:
Comparisons
Source-stated alternatives
The abstract explicitly mentions multiparametric MRI as another MRI approach currently in use. It also lists prostate-specific antigen testing, digital rectal examination, ultrasound-guided biopsy, and histological analysis as established diagnostic methods.
Source:
The abstract explicitly mentions multiparametric MRI as another MRI approach currently in use. It also lists prostate-specific antigen testing, digital rectal examination, ultrasound-guided biopsy, and histological analysis as established diagnostic methods.
Source-backed strengths
reported as accurate for diagnosing malignant prostate lesions in this retrospective cohort
Source:
reported as accurate for diagnosing malignant prostate lesions in this retrospective cohort
Compared with ultrasonography
The abstract explicitly mentions multiparametric MRI as another MRI approach currently in use. It also lists prostate-specific antigen testing, digital rectal examination, ultrasound-guided biopsy, and histological analysis as established diagnostic methods.
Shared frame: source-stated alternative in extracted literature
Strengths here: reported as accurate for diagnosing malignant prostate lesions in this retrospective cohort.
Relative tradeoffs: abstract does not report formal sensitivity, specificity, or comparison against multiparametric MRI; study is retrospective and limited to 50 pathologically confirmed cases.
Source:
The abstract explicitly mentions multiparametric MRI as another MRI approach currently in use. It also lists prostate-specific antigen testing, digital rectal examination, ultrasound-guided biopsy, and histological analysis as established diagnostic methods.
Ranked Citations
- 1.